These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4979994)

  • 1. A new butyrophenone derivative. AL-1021.
    Gallant DM; Bishop MP; Guerrero-Figueroa R; O'Meallie L
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):456-9. PubMed ID: 4979994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 3. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion].
    Simmelsgaard H; Mellergaard M; Vangtorp A
    Nord Med; 1967 Feb; 77(7):210-3. PubMed ID: 5336427
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 7. AHR-1900: a butyrophenone derivative.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):793-5. PubMed ID: 4984045
    [No Abstract]   [Full Text] [Related]  

  • 8. AL-499: a preliminary evaluation of a new butyrophenone derivative in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1968 May; 10(5):244-6. PubMed ID: 4967737
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study of AL-449 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of some butyrophenone derivatives].
    Bizoń E; Kakolewski J; Lewicka-Wysocka H
    Neurol Neurochir Psychiatr Pol; 1965; 15(6):889-92. PubMed ID: 5324994
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia].
    Weiser G
    Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 15. A pilot study of AL-1021 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
    [No Abstract]   [Full Text] [Related]  

  • 16. Further observations on trifluperidol: a butyrophenone derivative.
    Gallant DM; Bishop MP; Nesselhof WM; Sprehe DJ
    Psychopharmacologia; 1965 Jan; 7(1):37-43. PubMed ID: 5318922
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxic effects of a new butyrophenone compound. U-25,927.
    O'Meallie L; Gallant DM; Bishop MP; Bishop G; Steele CA
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):460-70. PubMed ID: 4979995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute schizophrenia with a new butyrophenone-lenperone.
    Harris M
    J Clin Pharmacol; 1975; 15(2-3):187-90. PubMed ID: 1091666
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the position of butyrophenone derivative Triperidol in psychiatric treatment].
    Lange E; Scholz V
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.